Long-term study of radiofrequency treatment for pancreatic tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study follows adults over time who are treated for a pancreatic tumor using ultrasound-guided radiofrequency through a thin needle. It aims to understand what happens after treatment and how patients do, so future care can improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You’re having a pancreatic tumor treated with ultrasound-guided radiofrequency using a thin needle
- A team of specialists has confirmed that this radiofrequency option is appropriate for you
- You can understand the study information and agree to participate
- You’re willing to return for scheduled follow-up visits
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether heating (radiofrequency) treatment guided by a special ultrasound scope can control small pancreatic neuroendocrine tumors. It may help patients whose tumors are very small and do not release hormones.
This trial tests a procedure that uses an endoscope and ultrasound to heat (radiofrequency ablate) pancreatic neuroendocrine tumors. It may help shrink tumors while aiming to be a less invasive option.
This trial is a database study that collects information from people who are referred for a procedure using endoscopic ultrasound and heat energy to treat a tumor or enlarged lymph nodes. Your data may help doctors learn how well this treatment works in different situations.
This trial tests combining endoscopic ultrasound-guided radiofrequency ablation with FOLFIRINOX chemotherapy for people with advanced pancreatic cancer that hasn't spread to other organs. It aims to see if this approach is safe and effective.
This study tests how safe and effective endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is for treating pancreatic growths that might become cancer or already are cancer. It is for people who are already scheduled to have this procedure as part of their care.
This Phase 2 trial tests whether a device that delivers carefully timed “radiofrequency heat” through the body can slow or control metastatic (spread) pancreatic cancer. You may qualify if you have newly diagnosed metastatic pancreatic cancer and can meet safety and blood-test requirements.
Hear when a new Pancreatic Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.